Ordinary Adjustment | Solactive Future Pharmaceutical Europe Index | Effective Date 6th September 2024
Solactive Future Pharmaceutical Europe Index:
In the ordinary adjustment, the following composition will be implemented effective open 6th September 2024:
| ARGENX SE |
| GENMAB A/S |
| ROCHE HOLDING AG |
| ASTRAZENECA PLC |
| UCB SA |
| GSK PLC |
| NOVARTIS AG |
| NOVO NORDISK A/S |
| RECORDATI SPA |
| SANOFI SA |
| BAYER AG |
| GALDERMA GROUP AG |
| MERCK KGAA |
| SANDOZ GROUP AG |
| SWEDISH ORPHAN BIOVITRUM AB |